Follow The Filings

ESQ Esquire Financial

Esquire Financial earnings company data as of 9:59 AM ET 10/23

Scheduled

1 period, newest first, nothing reported yet. Each row shows EPS above revenue.

Period Date Metric Estimate Actual Result
FY2026 Q3 27 Oct EPS 1.91 — —
Rev — — —

Insider trades

Open-market buys and sales by ESQ's executives, directors and 10% owners in the last 12 months, from their Form 4s

All ESQ insider trades
  • None no insider bought on the open market
  • $5M sold by 4 insiders outside a trading plan
  • None no planned (10b5-1) sales
  1. Andrew C Sagliocca CEO
    Sale
    $1.2M 10,000 shares at $122.73 3.3% of stake
    Traded Sep 18 Filed Sep 21
    ↗
  2. Robert Mitzman Director
    Sale
    $389K 3,000 shares at $129.60 2.1% of stake
    Traded Jul 30 Filed Aug 3
    ↗
  3. Richard T Powers Director
    Sale
    $242K 2,308 shares at $104.83 3.8% of stake
    Traded Mar 19 Filed Mar 20
    ↗
  4. Selig Zises Director
    Sale
    $3.2M 30,000 shares at $106.30 32% of stake
    Traded Mar 18–19 Filed Mar 20
    ↗

Also filed in the last 12 months, not counted as buying or selling: 18 share withholdings for taxes, 16 stock grants, 8 option exercises, and 1 gift.

SEC filings

Recent issuer filings from EDGAR, 21 shown.

Filed Form Detail Links
8-K/A 9.01 Filing Doc
10-Q Filing Doc
SCHEDULE 13G/A — Filing Doc
8-K 2.01,5.02,8.01,9.01 Filing Doc
8-K 8.01,9.01 Filing Doc
8-K 2.02,7.01,9.01 Filing Doc
8-K 5.07,8.01,9.01 Filing Doc
8-K 8.01,9.01 Filing Doc
8-K 5.07 Filing Doc
10-Q Filing Doc
424B3 Filing Doc
DEF 14A Filing Doc
8-K 8.01,9.01 Filing Doc
8-K 2.02,7.01,9.01 Filing Doc
8-K 5.02,9.01 Filing Doc
SCHEDULE 13G/A — Filing Doc
10-K Filing Doc
8-K 1.01,8.01,9.01 Filing Doc
8-K 8.01,9.01 Filing Doc
8-K 5.02,9.01 Filing Doc
8-K 2.02,7.01,9.01 Filing Doc

Source: SEC EDGAR submissions, updated 5 days ago. All on EDGAR

Estimates are consensus figures; SEC filings remain the official record. Not investment advice.